Cencora Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order … Read more
Cencora Inc. - Asset Resilience Ratio
Cencora Inc. (COR) has an Asset Resilience Ratio of 2.24% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2025)
This chart shows how Cencora Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Cencora Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.75 Billion | 2.24% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.75 Billion | 2.24% |
Asset Resilience Insights
- Limited Liquidity: Cencora Inc. maintains only 2.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Cencora Inc. Industry Peers by Asset Resilience Ratio
Compare Cencora Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Cencora Inc. (2006–2025)
The table below shows the annual Asset Resilience Ratio data for Cencora Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 5.69% | $4.36 Billion | $76.59 Billion | +1.02pp |
| 2024-09-30 | 4.67% | $3.13 Billion | $67.10 Billion | +0.53pp |
| 2023-09-30 | 4.14% | $2.59 Billion | $62.56 Billion | -1.85pp |
| 2022-09-30 | 5.99% | $3.39 Billion | $56.56 Billion | +0.90pp |
| 2021-09-30 | 5.09% | $2.92 Billion | $57.34 Billion | -5.29pp |
| 2020-09-30 | 10.38% | $4.60 Billion | $44.27 Billion | +10.31pp |
| 2016-09-30 | 0.08% | $26.10 Million | $33.59 Billion | -0.11pp |
| 2015-09-30 | 0.18% | $50.80 Million | $27.74 Billion | -3.61pp |
| 2007-09-30 | 3.80% | $467.42 Million | $12.31 Billion | +3.27pp |
| 2006-09-30 | 0.53% | $67.84 Million | $12.78 Billion | -- |